# Citius Oncology, Inc. (CTOR)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/CTOR/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 7.11M | $ -41.07M | $ -14.17M | $ 10.21M | $ 40.38M |
| 2025 | $ 0 | $ -25.35M | $ -5.67M | $ 3.80M | $ 44.87M |
| 2024 | $ 0 | $ -22.23M | $ 132.8K | $ 3.80M | $ 46.14M |
| 2023 | $ 0 | $ -13.73M | $ -114.1K | $ 0 | $ 25.54M |
| 2022 | $ 0 | $ -12.14M | N/A | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.25 |
| Liabilities / Eq | 1.78 |
| Current Ratio | 0.73 |

## Other views

- [Metrics](https://sponda.capital/en/CTOR.md)
- [Charts](https://sponda.capital/en/CTOR/charts.md)
- [Compare](https://sponda.capital/en/CTOR/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.